本研究针对天然产物开发需求，聚焦蕨类植物Athyrium filix-femina（Lady Fern）的药用价值挖掘。研究人员通过乙醇提取获得活性 ...

Investment company Athyrium Capital Management, LP (Current Portfolio) buys Recro Pharma Inc during the 3-months ended 2021Q1, according to the most recent filings of the investment company, Athyrium ...

本研究针对天然免疫调节剂开发需求，从多齿 Athyrium (Doll.) Ching 中提取纯化水溶性多糖(AFP)，通过FT-IR、UV-Vis、CD、SEM、AFM、CR ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

NEW YORK--(BUSINESS WIRE)--A consortium of investors led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc. today announced they have exited their ...

Athyrium Capital Management, Lp is an investment manager based in New York, NY with $157.7 M in assets under management.

Athyrium Funds purchased a portion of the royalties payable to Esperion on Japan net sales of Otsuka’s bempedoic acid products, together with related milestone payments, subject to a cap, for total ...

Athyrium Opportunities Fund LP, a private credit fund which invests in healthcare sector, has closed at $507 million. The Fund, which was oversubscribed, is jointly managed by Neuberger Berman and ...

Fintel reports that Athyrium Opportunities 2020 LP has filed a 13D/A form with the SEC disclosing ownership of 71,136,069 shares of Biora Therapeutics Inc (BIOR). This represents 28.4% of the company.